H-DRFYKSLRAEQTD-OH

Ref. 3D-PP45480

Informations sur le produit

• Nom: H-DRFYKSLRAEQTD-OH
• Synonymes: NH2-Asp-Arg-Phe-Tyr-Lys-Ser-Leu-Arg-Ala-Glu-Gln-Thr-Asp-OH

Description

Peptide H-DRFYKSLRAEQTD-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-DRFYKSLRAEQTD-OH include the following: Adenovirus serotype 5-specific neutralizing antibodies target multiple hexon hypervariable regions RR Bradley, LF Maxfield, DM Lynch - Journal of , 2012 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.06165-11 Adenovirus serotype 5 neutralizing antibodies target both hexon and fiber following vaccination and natural infection RR Bradley, DM Lynch, MJ Iampietro - Journal of , 2012 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.06254-11 of March 19, 2013. RAK Nabel, RA Seder, E Gomez, M Esteban , LS Wyatt - 2013 - academia.eduhttps://www.academia.edu/download/44935245/Comparative_Analysis_of_the_Magnitude_Qu20160420-15810-15wc64m.pdf Rapid cloning of novel rhesus adenoviral vaccine vectors P Abbink, M Kirilova, M Boyd, N Mercado , Z Li - Journal of , 2018 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/JVI.01924-17 Construction and evaluation of novel rhesus monkey adenovirus vaccine vectors P Abbink, LF Maxfield, D Ng'ang'a - Journal of , 2015 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.02950-14 Comparative seroprevalence and immunogenicity of six rare serotype recombinant adenovirus vaccine vectors from subgroups B and D P Abbink, AAC Lemckert, BA Ewald, DM Lynch - Journal of , 2007 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.02696-06 Antigen expression determines adenoviral vaccine potency independent of IFN and STING signaling KM Quinn , DE Zak, A Costa - The Journal of , 2015 - Am Soc Clin Investighttps://www.jci.org/articles/view/78280 Comparative analysis of the magnitude, quality, phenotype, and protective capacity of simian immunodeficiency virus gag-specific CD8+ T cells following human KM Quinn , A Da Costa, A Yamamoto - The Journal of , 2013 - journals.aai.orghttps://journals.aai.org/jimmunol/article/190/6/2720/87071 Comparative Analysis of the Magnitude, Quality, Phenotype and Protective Capacity of SIV Gag-Specific CD8+ T Cells Following Human-, Simian-and KM Quinn , A Da Costa, A Yamamoto - (Baltimore, Md.: 1950 , 2013 - ncbi.nlm.nih.govhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3594325/ Modulation of DNA Vaccine-Elicited CD8+ T-Lymphocyte Epitope Immunodominance Hierarchies J Liu, BA Ewald, DM Lynch, A Nanda - Journal of , 2006 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.01348-06 Immunogenicity of heterologous recombinant adenovirus prime-boost vaccine regimens is enhanced by circumventing vector cross-reactivity AR Thorner, AAC Lemckert, J Goudsmit - Journal of , 2006 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.01749-06 Adenoviral vectors: a possible road to an HIV vaccine AAC Lemckert - 2008 - dare.uva.nlhttps://dare.uva.nl/document/2/53333

• Marque: Biosynth